Tag: Risk Matrix

  • Continuing Trending of Monkeypox and Covid

    Continuing Trending of Monkeypox and Covid

    Key Points: COVID In today’s Recommendation for Industry, we discuss the continued trend of Monkeypox and Covid. Read more below. Regular physical activity tied to lower risk of COVID, poor outcomes. At least 150 minutes (2.5 hours) of moderate physical activity—or 75 minutes (1.2 hours) of vigorous exercise—weekly was linked to a lower risk of…

  • COVID Vaccines Continue to Evolve

    Key Points: In today’s Recommendation for Industry, we discuss the continuing evolution of COVID vaccines. Read more below. Feds look ahead to next-generation COVID vaccines. Federal officials have signaled that second boosters for those under 50 are on hold to speed production of new bivalent shots. The new bivalent booster shots will include the original…

  • COVID Cases Rise Again – but Don’t Overreact

    Key Points: In today’s Recommendation for Industry, we discuss how COVID cases are rising. Read more below. CDC panel recommends Novavax vaccine as BA.5 gains more ground. On July 19, CDC vaccine advisers unanimously approved recommended the use of the Novavax COVID-19 vaccine for the primary series for people 18 years and older. The CDC…

  • Westward Wave of COVID Continues – as Projected

    Key Points: In today’s Recommendation for Industry, we discuss the continued westward wave of COVID. Read more below. Coronavirus (COVID-19) Update: FDA Authorizes Emergency Use of Novavax COVID-19 Vaccine, Adjuvante. On July 13, the USDA issued an emergency use authorization for Novavax COVID-19, Adjuvante vaccine for individuals 18 years of age and older. The FDA…

  • Current Status & Trajectory of COVID

    Key Points: In today’s Recommendation for Industry, we discuss the continued westward movement of COVID in the U.S. Read more below. BA.4/5 COVID-19 variants now dominant in all US regions. Combined, the two subvariants make up more than 70% of recently sequenced samples, up sharply from 52.3% the previous week. Of the variants CDC is…

  • COVID Westward Migration Continues

    Key Points: In today’s Recommendation for Industry, we take a look at the latest statistics on COVID and expectations for the next few months. Read more below. FDA advisory committee is recommending Omicron variant to be within COVID boosters. The proportion of BA.4 and BA.5 increased in the week ending June 25th, mainly due to…

  • COVID: Progressive Trajectories Very Encouraging

    Key Points: In today’s Recommendation for Industry, we discuss the encouraging trajectory of COVID based on TAG’s matrix and CDC’s mapping. Read more below. Women more likely to have long COVID, different symptom profile. For the shorter-term COVID, females were more likely than males to experience issues related to mood; ear, nose, and throat; musculoskeletal;…

  • COVID Trends Continue, but Severity Remains Low

    Key Points: In today’s Recommendation for Industry, we discuss the current data on COVID case rates and hospitalizations. Read more below. FDA committee approves Moderna COVID vaccine for kids 6 to 17. Previously only Pfizer was approved for ages 5-17 and the CDC had recommended that age range receive a single-dose booster. The CDC reports…

  • COVID U.S.: Surge Moving Westward; BA.4 and BA.5 Increasing

    Key Points: In today’s Recommendation for Industry, we discuss the westward movement of COVID and increase of BA.4 and BA. 5 in the U.S. Read more below. Reporting Home COVID Test Results Can Be Confusing. Here’s How to Do It. The Centers for Disease Control and Prevention “strongly encourages” everyone who self-tests to report their…

  • Cases Seem to be Improving and Moving Across the Country

    Key Points: In today’s Recommendation for Industry, we discuss how cases seem to be improving and moving across the country, as shown through the CDC community levels map and our weekly matrix. Read more below. Global COVID-19 cases fall 11%, deaths drop 3%. Since January, cases have steadily fallen over the world. Some areas of…